Can tofacitinib be used to treat steroid-refractory immune checkpoint inhibitor-associated myocarditis?
Immune checkpoint inhibitors are powerful cancer treatments but can cause severe heart inflammation called myocarditis. When this condition does not improve with high-dose steroids, it is called steroid-refractory. This form of the disease is life-threatening and has limited treatment options. Tofacitinib, a medication that blocks specific immune signals, has been used in these difficult cases with some success.
What the research says
Two case reports describe patients with severe multi-organ inflammation, including myocarditis, who did not respond to high-dose steroids or other standard drugs like mycophenolate mofetil. In both instances, adding tofacitinib led to significant improvement in symptoms and lab findings 46. One patient had a pulmonary fungal infection and oral sores after taking the drug, which were managed with supportive care 4.
Another case involved a patient with nasopharyngeal carcinoma who developed myocarditis after cancer therapy. High-dose steroids and intravenous immunoglobulin failed to lower heart enzyme levels. Treatment with tofacitinib, which targets a specific immune pathway, successfully helped the patient recover without major heart events 5.
A 2024 review of available treatments suggests that tofacitinib is a preferred option for steroid-refractory myocarditis that is rapidly progressing or involves high levels of interleukin-6 7. The review also notes that if the patient also has myositis (muscle inflammation), tofacitinib is part of a preferred combination therapy approach 7.
What to ask your doctor
- Is my case of myocarditis considered steroid-refractory based on my current treatment response?
- Does my condition involve high levels of interleukin-6 or rapid progression that might make tofacitinib a suitable option?
- Am I also experiencing myositis or other muscle inflammation that would change the treatment plan?
- What are the potential side effects of tofacitinib, such as mouth sores or infections, and how would they be managed?
- Are there specific monitoring plans needed if we decide to try tofacitinib for my heart inflammation?
This question is drawn from common patient questions about Pulmonology & Critical Care and answered using cited medical research. We do not provide individualized advice.